ImmunityBio, Inc. (IBRX)
7.10
-0.30
(-4.05%)
USD |
NASDAQ |
Jul 24, 16:00
7.10
0.00 (0.00%)
After-Hours: 20:00
ImmunityBio Market Cap : 7.436B for July 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| July 24, 2026 | 7.436B |
| July 23, 2026 | 7.750B |
| July 22, 2026 | 7.866B |
| July 21, 2026 | 8.452B |
| July 20, 2026 | 7.850B |
| July 17, 2026 | 8.044B |
| July 16, 2026 | 7.803B |
| July 15, 2026 | 8.096B |
| July 14, 2026 | 8.253B |
| July 13, 2026 | 8.159B |
| July 10, 2026 | 8.609B |
| July 09, 2026 | 9.290B |
| July 08, 2026 | 9.217B |
| July 07, 2026 | 9.175B |
| July 06, 2026 | 9.332B |
| July 02, 2026 | 9.887B |
| July 01, 2026 | 9.636B |
| June 30, 2026 | 9.169B |
| June 29, 2026 | 9.185B |
| June 26, 2026 | 9.122B |
| June 25, 2026 | 8.159B |
| June 24, 2026 | 8.169B |
| June 23, 2026 | 7.667B |
| June 22, 2026 | 7.562B |
| June 18, 2026 | 7.708B |
| Date | Value |
|---|---|
| June 17, 2026 | 7.321B |
| June 16, 2026 | 7.038B |
| June 15, 2026 | 7.468B |
| June 12, 2026 | 7.436B |
| June 11, 2026 | 7.541B |
| June 10, 2026 | 7.310B |
| June 09, 2026 | 7.593B |
| June 08, 2026 | 7.509B |
| June 05, 2026 | 7.248B |
| June 04, 2026 | 7.635B |
| June 03, 2026 | 7.520B |
| June 02, 2026 | 7.572B |
| June 01, 2026 | 7.583B |
| May 29, 2026 | 7.876B |
| May 28, 2026 | 8.085B |
| May 27, 2026 | 8.264B |
| May 26, 2026 | 8.295B |
| May 22, 2026 | 7.562B |
| May 21, 2026 | 8.107B |
| May 20, 2026 | 8.431B |
| May 19, 2026 | 8.127B |
| May 18, 2026 | 8.379B |
| May 15, 2026 | 8.347B |
| May 14, 2026 | 8.536B |
| May 13, 2026 | 8.536B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 12.03B |
| Sarepta Therapeutics, Inc. | 1.655B |
| Cogent Biosciences, Inc. | 6.792B |
| Revolution Medicines, Inc. | 37.88B |
| Erasca, Inc. | 5.940B |
Market Cap Related Metrics
| PS Ratio | 48.49 |
| PEG Ratio | -0.1806 |
| Price | 7.10 |
| Earnings Yield | -12.03% |
| PEGY Ratio | -0.1806 |